Quick Heal Technologies Ltd

Quick Heal Tech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Quick Heal Technologies Ltd

₹ 486 0.32%
03 May - close price
quickheal.com BSE: 539678 NSE : QUICKHEAL
About

Quick Heal Technologies is engaged in the business of providing security software products. The Company caters to both domestic and international market.

Key Points

Market Presence
With over 30% of the market share in India and a nationwide distribution channel comprising over 200 Tier I distributors and over 30,000 Tier II and Tier III distributors in the retail segment. A robust country-wide distribution network comprising more than 30,000 distributors in 22 cities of India and an International presence in around 47 countries, further supported by operational entities in five countries and very high brand value derived from well-entrenched industry presence and expertise for more than 25+ years. [1] [2]

Website BSE NSE
  • Market Cap ₹ 2,601 Cr.
  • Current Price ₹ 486
  • High / Low ₹ 600 / 136
  • Stock P/E 107
  • Book Value ₹ 81.7
  • Dividend Yield 0.51 %
  • ROCE 6.15 %
  • ROE 5.66 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 102%

Cons

  • Stock is trading at 5.95 times its book value
  • The company has delivered a poor sales growth of -1.52% over past five years.
  • Company has a low return on equity of 6.39% over last 3 years.
  • Earnings include an other income of Rs.21.4 Cr.
  • Company has high debtors of 165 days.
  • Working capital days have increased from 167 days to 316 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
105 55 104 80 104 61 101 67 49 51 78 82 80
52 50 57 59 69 60 73 78 65 67 67 70 70
Operating Profit 54 5 46 20 35 1 28 -11 -16 -15 11 12 10
OPM % 51% 9% 45% 26% 34% 2% 28% -17% -33% -29% 14% 14% 13%
6 6 4 4 6 3 5 3 10 5 6 4 7
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 5 4 4 5 5 4 4 4 4 3 3 3 3
Profit before tax 54 7 46 20 36 0 30 -12 -10 -13 13 13 14
Tax % 27% 16% 24% 27% 22% 40% 25% 23% 33% 4% 4% 20% -4%
40 6 35 14 28 0 22 -9 -7 -13 13 10 14
EPS in Rs 6.18 1.07 5.98 2.46 4.84 0.03 3.82 -1.75 -1.25 -2.40 2.43 1.89 2.62
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
205 243 286 302 300 318 315 286 333 342 278 292
101 157 194 200 210 198 187 195 192 235 276 274
Operating Profit 104 85 92 102 90 120 128 92 141 107 2 18
OPM % 51% 35% 32% 34% 30% 38% 41% 32% 42% 31% 1% 6%
11 11 8 10 25 30 33 31 24 19 22 21
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 4 11 20 24 31 27 24 22 19 17 16 13
Profit before tax 110 86 80 88 84 123 137 101 146 109 8 26
Tax % 30% 32% 33% 34% 37% 33% 33% 27% 27% 23% 20% 8%
77 58 54 58 53 83 92 74 107 83 6 24
EPS in Rs 100.74 9.56 8.81 8.27 7.59 11.79 13.01 11.59 16.66 14.34 1.21 4.53
Dividend Payout % 2% 78% 85% 30% 33% 25% 15% 35% 24% 31% 207% 66%
Compounded Sales Growth
10 Years: 2%
5 Years: -2%
3 Years: -4%
TTM: 5%
Compounded Profit Growth
10 Years: -8%
5 Years: -23%
3 Years: -39%
TTM: 2856%
Stock Price CAGR
10 Years: %
5 Years: 17%
3 Years: 39%
1 Year: 246%
Return on Equity
10 Years: 10%
5 Years: 9%
3 Years: 6%
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 8 61 61 70 70 70 71 64 64 58 53 54
Reserves 277 271 270 559 592 653 719 580 687 570 367 383
0 0 0 0 0 0 0 0 0 0 0 0
29 47 97 88 72 57 63 52 75 88 74 76
Total Liabilities 314 380 428 717 734 781 853 697 827 716 493 513
38 82 111 142 185 173 165 158 146 137 124 117
CWIP 29 55 74 55 14 14 11 3 2 0 0 3
Investments 139 131 130 115 182 306 390 310 416 318 198 190
107 111 113 405 353 287 288 225 263 261 171 203
Total Assets 314 380 428 717 734 781 853 697 827 716 493 513

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
68 61 77 78 36 94 61 71 99 80 31 18
-63 -59 -53 -163 -73 -122 -37 148 -92 126 185 6
-1 -2 -18 189 -20 -19 -24 -221 0 -214 -212 2
Net Cash Flow 4 -1 7 104 -57 -47 1 -3 6 -9 4 26

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 138 104 83 112 118 118 145 144 165 184 161 165
Inventory Days 181 144
Days Payable 864 1,103
Cash Conversion Cycle 138 104 -600 -847 118 118 145 144 165 184 161 165
Working Capital Days 103 52 -23 29 49 70 92 94 98 102 83 316
ROCE % 44% 27% 24% 18% 14% 18% 18% 14% 21% 15% 0%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
73.02% 72.99% 72.92% 72.86% 72.84% 72.78% 73.08% 73.08% 73.08% 73.06% 72.76% 72.48%
0.52% 0.97% 1.57% 1.77% 1.74% 1.76% 2.17% 2.04% 2.02% 1.56% 1.66% 1.65%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.13% 1.44% 2.06%
26.47% 26.04% 25.51% 25.37% 25.42% 25.45% 24.76% 24.89% 24.91% 24.23% 24.13% 23.81%
No. of Shareholders 63,17369,62166,99267,49166,76975,04466,02865,11963,44557,52850,24946,923

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls